Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001641172-25-001610
Filing Date
2025-03-31
Accepted
2025-03-31 14:25:31
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-03-31

Document Format Files

Seq Description Document Type Size
1 formnt10-k.htm NT 10-K 27786
  Complete submission text file 0001641172-25-001610.txt   29067
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 000-21990 | Film No.: 25791707
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)